[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global PSMA Antibody Market Growth 2022-2028

December 2022 | 102 pages | ID: G26B3422B023EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

PSMA Antibody is an unconjugated antibody to PSMA.

The global market for PSMA Antibody is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC PSMA Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States PSMA Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe PSMA Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China PSMA Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key PSMA Antibody players cover Sino Biological, Inc., ACROBiosystems, Bio-Techne, ??Abcam and Elabscience Biotechnology Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage

This latest report provides a deep insight into the global PSMA Antibody market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global PSMA Antibody market, with both quantitative and qualitative data, to help readers understand how the PSMA Antibody market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:

The study segments the PSMA Antibody market and forecasts the market size by Type (Monoclonal Antibody and Polyclonal Antibody,), by Application (Flow Cytometry, ELISA, Western Blot and Immunoprecipitation), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
  • Monoclonal Antibody
  • Polyclonal Antibody
Segmentation by application
  • Flow Cytometry
  • ELISA
  • Western Blot
  • Immunoprecipitation
  • Immunofluorescence
  • Other
Segmentation by region
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
Major companies covered
  • Sino Biological, Inc.
  • ACROBiosystems
  • Bio-Techne
  • ??Abcam
  • Elabscience Biotechnology Inc.
  • LifeSpan BioSciences, Inc
  • ProSci Incorporated
  • Boster Biological Technology
  • Abbexa
  • Assay Genie
  • Innovative Research
  • G&P Biosciences
  • Arigo Biolaboratories Corp.
Chapter Introduction

Chapter 1: Scope of PSMA Antibody, Research Methodology, etc.

Chapter 2: Executive Summary, global PSMA Antibody market size (sales and revenue) and CAGR, PSMA Antibody market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.

Chapter 3: PSMA Antibody sales, revenue, average price, global market share, and industry ranking by company, 2017-2022

Chapter 4: Global PSMA Antibody sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.

Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.

Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace

Chapter 10: Manufacturing cost structure analysis

Chapter 11: Sales channel, distributors, and customers

Chapter 12: Global PSMA Antibody market size forecast by region, by country, by type, and application.

Chapter 13: Comprehensive company profiles of the leading players, including Sino Biological, Inc., ACROBiosystems, Bio-Techne, ??Abcam, Elabscience Biotechnology Inc., LifeSpan BioSciences, Inc, ProSci Incorporated, Boster Biological Technology and Abbexa, etc.

Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global PSMA Antibody Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for PSMA Antibody by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for PSMA Antibody by Country/Region, 2017, 2022 & 2028
2.2 PSMA Antibody Segment by Type
  2.2.1 Monoclonal Antibody
  2.2.2 Polyclonal Antibody
2.3 PSMA Antibody Sales by Type
  2.3.1 Global PSMA Antibody Sales Market Share by Type (2017-2022)
  2.3.2 Global PSMA Antibody Revenue and Market Share by Type (2017-2022)
  2.3.3 Global PSMA Antibody Sale Price by Type (2017-2022)
2.4 PSMA Antibody Segment by Application
  2.4.1 Flow Cytometry
  2.4.2 ELISA
  2.4.3 Western Blot
  2.4.4 Immunoprecipitation
  2.4.5 Immunofluorescence
  2.4.6 Other
2.5 PSMA Antibody Sales by Application
  2.5.1 Global PSMA Antibody Sale Market Share by Application (2017-2022)
  2.5.2 Global PSMA Antibody Revenue and Market Share by Application (2017-2022)
  2.5.3 Global PSMA Antibody Sale Price by Application (2017-2022)

3 GLOBAL PSMA ANTIBODY BY COMPANY

3.1 Global PSMA Antibody Breakdown Data by Company
  3.1.1 Global PSMA Antibody Annual Sales by Company (2020-2022)
  3.1.2 Global PSMA Antibody Sales Market Share by Company (2020-2022)
3.2 Global PSMA Antibody Annual Revenue by Company (2020-2022)
  3.2.1 Global PSMA Antibody Revenue by Company (2020-2022)
  3.2.2 Global PSMA Antibody Revenue Market Share by Company (2020-2022)
3.3 Global PSMA Antibody Sale Price by Company
3.4 Key Manufacturers PSMA Antibody Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers PSMA Antibody Product Location Distribution
  3.4.2 Players PSMA Antibody Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR PSMA ANTIBODY BY GEOGRAPHIC REGION

4.1 World Historic PSMA Antibody Market Size by Geographic Region (2017-2022)
  4.1.1 Global PSMA Antibody Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global PSMA Antibody Annual Revenue by Geographic Region
4.2 World Historic PSMA Antibody Market Size by Country/Region (2017-2022)
  4.2.1 Global PSMA Antibody Annual Sales by Country/Region (2017-2022)
  4.2.2 Global PSMA Antibody Annual Revenue by Country/Region
4.3 Americas PSMA Antibody Sales Growth
4.4 APAC PSMA Antibody Sales Growth
4.5 Europe PSMA Antibody Sales Growth
4.6 Middle East & Africa PSMA Antibody Sales Growth

5 AMERICAS

5.1 Americas PSMA Antibody Sales by Country
  5.1.1 Americas PSMA Antibody Sales by Country (2017-2022)
  5.1.2 Americas PSMA Antibody Revenue by Country (2017-2022)
5.2 Americas PSMA Antibody Sales by Type
5.3 Americas PSMA Antibody Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC PSMA Antibody Sales by Region
  6.1.1 APAC PSMA Antibody Sales by Region (2017-2022)
  6.1.2 APAC PSMA Antibody Revenue by Region (2017-2022)
6.2 APAC PSMA Antibody Sales by Type
6.3 APAC PSMA Antibody Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe PSMA Antibody by Country
  7.1.1 Europe PSMA Antibody Sales by Country (2017-2022)
  7.1.2 Europe PSMA Antibody Revenue by Country (2017-2022)
7.2 Europe PSMA Antibody Sales by Type
7.3 Europe PSMA Antibody Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa PSMA Antibody by Country
  8.1.1 Middle East & Africa PSMA Antibody Sales by Country (2017-2022)
  8.1.2 Middle East & Africa PSMA Antibody Revenue by Country (2017-2022)
8.2 Middle East & Africa PSMA Antibody Sales by Type
8.3 Middle East & Africa PSMA Antibody Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PSMA Antibody
10.3 Manufacturing Process Analysis of PSMA Antibody
10.4 Industry Chain Structure of PSMA Antibody

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 PSMA Antibody Distributors
11.3 PSMA Antibody Customer

12 WORLD FORECAST REVIEW FOR PSMA ANTIBODY BY GEOGRAPHIC REGION

12.1 Global PSMA Antibody Market Size Forecast by Region
  12.1.1 Global PSMA Antibody Forecast by Region (2023-2028)
  12.1.2 Global PSMA Antibody Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global PSMA Antibody Forecast by Type
12.7 Global PSMA Antibody Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Sino Biological, Inc.
  13.1.1 Sino Biological, Inc. Company Information
  13.1.2 Sino Biological, Inc. PSMA Antibody Product Offered
  13.1.3 Sino Biological, Inc. PSMA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Sino Biological, Inc. Main Business Overview
  13.1.5 Sino Biological, Inc. Latest Developments
13.2 ACROBiosystems
  13.2.1 ACROBiosystems Company Information
  13.2.2 ACROBiosystems PSMA Antibody Product Offered
  13.2.3 ACROBiosystems PSMA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 ACROBiosystems Main Business Overview
  13.2.5 ACROBiosystems Latest Developments
13.3 Bio-Techne
  13.3.1 Bio-Techne Company Information
  13.3.2 Bio-Techne PSMA Antibody Product Offered
  13.3.3 Bio-Techne PSMA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Bio-Techne Main Business Overview
  13.3.5 Bio-Techne Latest Developments
13.4 ??Abcam
  13.4.1 ??Abcam Company Information
  13.4.2 ??Abcam PSMA Antibody Product Offered
  13.4.3 ??Abcam PSMA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 ??Abcam Main Business Overview
  13.4.5 ??Abcam Latest Developments
13.5 Elabscience Biotechnology Inc.
  13.5.1 Elabscience Biotechnology Inc. Company Information
  13.5.2 Elabscience Biotechnology Inc. PSMA Antibody Product Offered
  13.5.3 Elabscience Biotechnology Inc. PSMA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Elabscience Biotechnology Inc. Main Business Overview
  13.5.5 Elabscience Biotechnology Inc. Latest Developments
13.6 LifeSpan BioSciences, Inc
  13.6.1 LifeSpan BioSciences, Inc Company Information
  13.6.2 LifeSpan BioSciences, Inc PSMA Antibody Product Offered
  13.6.3 LifeSpan BioSciences, Inc PSMA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 LifeSpan BioSciences, Inc Main Business Overview
  13.6.5 LifeSpan BioSciences, Inc Latest Developments
13.7 ProSci Incorporated
  13.7.1 ProSci Incorporated Company Information
  13.7.2 ProSci Incorporated PSMA Antibody Product Offered
  13.7.3 ProSci Incorporated PSMA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 ProSci Incorporated Main Business Overview
  13.7.5 ProSci Incorporated Latest Developments
13.8 Boster Biological Technology
  13.8.1 Boster Biological Technology Company Information
  13.8.2 Boster Biological Technology PSMA Antibody Product Offered
  13.8.3 Boster Biological Technology PSMA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Boster Biological Technology Main Business Overview
  13.8.5 Boster Biological Technology Latest Developments
13.9 Abbexa
  13.9.1 Abbexa Company Information
  13.9.2 Abbexa PSMA Antibody Product Offered
  13.9.3 Abbexa PSMA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Abbexa Main Business Overview
  13.9.5 Abbexa Latest Developments
13.10 Assay Genie
  13.10.1 Assay Genie Company Information
  13.10.2 Assay Genie PSMA Antibody Product Offered
  13.10.3 Assay Genie PSMA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 Assay Genie Main Business Overview
  13.10.5 Assay Genie Latest Developments
13.11 Innovative Research
  13.11.1 Innovative Research Company Information
  13.11.2 Innovative Research PSMA Antibody Product Offered
  13.11.3 Innovative Research PSMA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
  13.11.4 Innovative Research Main Business Overview
  13.11.5 Innovative Research Latest Developments
13.12 G&P Biosciences
  13.12.1 G&P Biosciences Company Information
  13.12.2 G&P Biosciences PSMA Antibody Product Offered
  13.12.3 G&P Biosciences PSMA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
  13.12.4 G&P Biosciences Main Business Overview
  13.12.5 G&P Biosciences Latest Developments
13.13 Arigo Biolaboratories Corp.
  13.13.1 Arigo Biolaboratories Corp. Company Information
  13.13.2 Arigo Biolaboratories Corp. PSMA Antibody Product Offered
  13.13.3 Arigo Biolaboratories Corp. PSMA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
  13.13.4 Arigo Biolaboratories Corp. Main Business Overview
  13.13.5 Arigo Biolaboratories Corp. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. PSMA Antibody Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. PSMA Antibody Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Monoclonal Antibody
Table 4. Major Players of Polyclonal Antibody
Table 5. Global PSMA Antibody Sales by Type (2017-2022) & (K Units)
Table 6. Global PSMA Antibody Sales Market Share by Type (2017-2022)
Table 7. Global PSMA Antibody Revenue by Type (2017-2022) & ($ million)
Table 8. Global PSMA Antibody Revenue Market Share by Type (2017-2022)
Table 9. Global PSMA Antibody Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global PSMA Antibody Sales by Application (2017-2022) & (K Units)
Table 11. Global PSMA Antibody Sales Market Share by Application (2017-2022)
Table 12. Global PSMA Antibody Revenue by Application (2017-2022)
Table 13. Global PSMA Antibody Revenue Market Share by Application (2017-2022)
Table 14. Global PSMA Antibody Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global PSMA Antibody Sales by Company (2020-2022) & (K Units)
Table 16. Global PSMA Antibody Sales Market Share by Company (2020-2022)
Table 17. Global PSMA Antibody Revenue by Company (2020-2022) ($ Millions)
Table 18. Global PSMA Antibody Revenue Market Share by Company (2020-2022)
Table 19. Global PSMA Antibody Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers PSMA Antibody Producing Area Distribution and Sales Area
Table 21. Players PSMA Antibody Products Offered
Table 22. PSMA Antibody Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global PSMA Antibody Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global PSMA Antibody Sales Market Share Geographic Region (2017-2022)
Table 27. Global PSMA Antibody Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global PSMA Antibody Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global PSMA Antibody Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global PSMA Antibody Sales Market Share by Country/Region (2017-2022)
Table 31. Global PSMA Antibody Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global PSMA Antibody Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas PSMA Antibody Sales by Country (2017-2022) & (K Units)
Table 34. Americas PSMA Antibody Sales Market Share by Country (2017-2022)
Table 35. Americas PSMA Antibody Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas PSMA Antibody Revenue Market Share by Country (2017-2022)
Table 37. Americas PSMA Antibody Sales by Type (2017-2022) & (K Units)
Table 38. Americas PSMA Antibody Sales Market Share by Type (2017-2022)
Table 39. Americas PSMA Antibody Sales by Application (2017-2022) & (K Units)
Table 40. Americas PSMA Antibody Sales Market Share by Application (2017-2022)
Table 41. APAC PSMA Antibody Sales by Region (2017-2022) & (K Units)
Table 42. APAC PSMA Antibody Sales Market Share by Region (2017-2022)
Table 43. APAC PSMA Antibody Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC PSMA Antibody Revenue Market Share by Region (2017-2022)
Table 45. APAC PSMA Antibody Sales by Type (2017-2022) & (K Units)
Table 46. APAC PSMA Antibody Sales Market Share by Type (2017-2022)
Table 47. APAC PSMA Antibody Sales by Application (2017-2022) & (K Units)
Table 48. APAC PSMA Antibody Sales Market Share by Application (2017-2022)
Table 49. Europe PSMA Antibody Sales by Country (2017-2022) & (K Units)
Table 50. Europe PSMA Antibody Sales Market Share by Country (2017-2022)
Table 51. Europe PSMA Antibody Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe PSMA Antibody Revenue Market Share by Country (2017-2022)
Table 53. Europe PSMA Antibody Sales by Type (2017-2022) & (K Units)
Table 54. Europe PSMA Antibody Sales Market Share by Type (2017-2022)
Table 55. Europe PSMA Antibody Sales by Application (2017-2022) & (K Units)
Table 56. Europe PSMA Antibody Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa PSMA Antibody Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa PSMA Antibody Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa PSMA Antibody Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa PSMA Antibody Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa PSMA Antibody Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa PSMA Antibody Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa PSMA Antibody Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa PSMA Antibody Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of PSMA Antibody
Table 66. Key Market Challenges & Risks of PSMA Antibody
Table 67. Key Industry Trends of PSMA Antibody
Table 68. PSMA Antibody Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. PSMA Antibody Distributors List
Table 71. PSMA Antibody Customer List
Table 72. Global PSMA Antibody Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global PSMA Antibody Sales Market Forecast by Region
Table 74. Global PSMA Antibody Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global PSMA Antibody Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas PSMA Antibody Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas PSMA Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC PSMA Antibody Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC PSMA Antibody Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe PSMA Antibody Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe PSMA Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa PSMA Antibody Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa PSMA Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global PSMA Antibody Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global PSMA Antibody Sales Market Share Forecast by Type (2023-2028)
Table 86. Global PSMA Antibody Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global PSMA Antibody Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global PSMA Antibody Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global PSMA Antibody Sales Market Share Forecast by Application (2023-2028)
Table 90. Global PSMA Antibody Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global PSMA Antibody Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sino Biological, Inc. Basic Information, PSMA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 93. Sino Biological, Inc. PSMA Antibody Product Offered
Table 94. Sino Biological, Inc. PSMA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Sino Biological, Inc. Main Business
Table 96. Sino Biological, Inc. Latest Developments
Table 97. ACROBiosystems Basic Information, PSMA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 98. ACROBiosystems PSMA Antibody Product Offered
Table 99. ACROBiosystems PSMA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. ACROBiosystems Main Business
Table 101. ACROBiosystems Latest Developments
Table 102. Bio-Techne Basic Information, PSMA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 103. Bio-Techne PSMA Antibody Product Offered
Table 104. Bio-Techne PSMA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Bio-Techne Main Business
Table 106. Bio-Techne Latest Developments
Table 107. ??Abcam Basic Information, PSMA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 108. ??Abcam PSMA Antibody Product Offered
Table 109. ??Abcam PSMA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. ??Abcam Main Business
Table 111. ??Abcam Latest Developments
Table 112. Elabscience Biotechnology Inc. Basic Information, PSMA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 113. Elabscience Biotechnology Inc. PSMA Antibody Product Offered
Table 114. Elabscience Biotechnology Inc. PSMA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Elabscience Biotechnology Inc. Main Business
Table 116. Elabscience Biotechnology Inc. Latest Developments
Table 117. LifeSpan BioSciences, Inc Basic Information, PSMA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 118. LifeSpan BioSciences, Inc PSMA Antibody Product Offered
Table 119. LifeSpan BioSciences, Inc PSMA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. LifeSpan BioSciences, Inc Main Business
Table 121. LifeSpan BioSciences, Inc Latest Developments
Table 122. ProSci Incorporated Basic Information, PSMA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 123. ProSci Incorporated PSMA Antibody Product Offered
Table 124. ProSci Incorporated PSMA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. ProSci Incorporated Main Business
Table 126. ProSci Incorporated Latest Developments
Table 127. Boster Biological Technology Basic Information, PSMA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 128. Boster Biological Technology PSMA Antibody Product Offered
Table 129. Boster Biological Technology PSMA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Boster Biological Technology Main Business
Table 131. Boster Biological Technology Latest Developments
Table 132. Abbexa Basic Information, PSMA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 133. Abbexa PSMA Antibody Product Offered
Table 134. Abbexa PSMA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Abbexa Main Business
Table 136. Abbexa Latest Developments
Table 137. Assay Genie Basic Information, PSMA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 138. Assay Genie PSMA Antibody Product Offered
Table 139. Assay Genie PSMA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Assay Genie Main Business
Table 141. Assay Genie Latest Developments
Table 142. Innovative Research Basic Information, PSMA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 143. Innovative Research PSMA Antibody Product Offered
Table 144. Innovative Research PSMA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Innovative Research Main Business
Table 146. Innovative Research Latest Developments
Table 147. G&P Biosciences Basic Information, PSMA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 148. G&P Biosciences PSMA Antibody Product Offered
Table 149. G&P Biosciences PSMA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. G&P Biosciences Main Business
Table 151. G&P Biosciences Latest Developments
Table 152. Arigo Biolaboratories Corp. Basic Information, PSMA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 153. Arigo Biolaboratories Corp. PSMA Antibody Product Offered
Table 154. Arigo Biolaboratories Corp. PSMA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Arigo Biolaboratories Corp. Main Business
Table 156. Arigo Biolaboratories Corp. Latest Developments

LIST OF FIGURES

Figure 1. Picture of PSMA Antibody
Figure 2. PSMA Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PSMA Antibody Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global PSMA Antibody Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. PSMA Antibody Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Monoclonal Antibody
Figure 10. Product Picture of Polyclonal Antibody
Figure 11. Global PSMA Antibody Sales Market Share by Type in 2021
Figure 12. Global PSMA Antibody Revenue Market Share by Type (2017-2022)
Figure 13. PSMA Antibody Consumed in Flow Cytometry
Figure 14. Global PSMA Antibody Market: Flow Cytometry (2017-2022) & (K Units)
Figure 15. PSMA Antibody Consumed in ELISA
Figure 16. Global PSMA Antibody Market: ELISA (2017-2022) & (K Units)
Figure 17. PSMA Antibody Consumed in Western Blot
Figure 18. Global PSMA Antibody Market: Western Blot (2017-2022) & (K Units)
Figure 19. PSMA Antibody Consumed in Immunoprecipitation
Figure 20. Global PSMA Antibody Market: Immunoprecipitation (2017-2022) & (K Units)
Figure 21. PSMA Antibody Consumed in Immunofluorescence
Figure 22. Global PSMA Antibody Market: Immunofluorescence (2017-2022) & (K Units)
Figure 23. PSMA Antibody Consumed in Other
Figure 24. Global PSMA Antibody Market: Other (2017-2022) & (K Units)
Figure 25. Global PSMA Antibody Sales Market Share by Application (2017-2022)
Figure 26. Global PSMA Antibody Revenue Market Share by Application in 2021
Figure 27. PSMA Antibody Revenue Market by Company in 2021 ($ Million)
Figure 28. Global PSMA Antibody Revenue Market Share by Company in 2021
Figure 29. Global PSMA Antibody Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global PSMA Antibody Revenue Market Share by Geographic Region in 2021
Figure 31. Global PSMA Antibody Sales Market Share by Region (2017-2022)
Figure 32. Global PSMA Antibody Revenue Market Share by Country/Region in 2021
Figure 33. Americas PSMA Antibody Sales 2017-2022 (K Units)
Figure 34. Americas PSMA Antibody Revenue 2017-2022 ($ Millions)
Figure 35. APAC PSMA Antibody Sales 2017-2022 (K Units)
Figure 36. APAC PSMA Antibody Revenue 2017-2022 ($ Millions)
Figure 37. Europe PSMA Antibody Sales 2017-2022 (K Units)
Figure 38. Europe PSMA Antibody Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa PSMA Antibody Sales 2017-2022 (K Units)
Figure 40. Middle East & Africa PSMA Antibody Revenue 2017-2022 ($ Millions)
Figure 41. Americas PSMA Antibody Sales Market Share by Country in 2021
Figure 42. Americas PSMA Antibody Revenue Market Share by Country in 2021
Figure 43. United States PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC PSMA Antibody Sales Market Share by Region in 2021
Figure 48. APAC PSMA Antibody Revenue Market Share by Regions in 2021
Figure 49. China PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 53. India PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe PSMA Antibody Sales Market Share by Country in 2021
Figure 56. Europe PSMA Antibody Revenue Market Share by Country in 2021
Figure 57. Germany PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 58. France PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa PSMA Antibody Sales Market Share by Country in 2021
Figure 63. Middle East & Africa PSMA Antibody Revenue Market Share by Country in 2021
Figure 64. Egypt PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country PSMA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of PSMA Antibody in 2021
Figure 70. Manufacturing Process Analysis of PSMA Antibody
Figure 71. Industry Chain Structure of PSMA Antibody
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles


More Publications